Matisse Capital’s InflaRx IFRX Stock Holding History

Matisse Capital’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,902	Closed	-$203K	–	108
2018 Q3	$203K	Buy	+5,902	New	+$190K	0.18%	105

Other funds holding IFRX

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Matisse Capital's IFRX Position: Q4 2018 in Review

Matisse Capital sold out of InflaRx (IFRX) in Q4 2018, closing a stake of 5,902 shares — an estimated $203K sold.

Matisse Capital first reported a position in IFRX in Q3 2018 and held it in 1 quarter. The position peaked at $203K in Q3 2018. 34 funds tracked by Wall St. Rank hold IFRX as of Q4 2018.

Matisse Capital reported no remaining InflaRx position as of Q4 2018 after selling out during the quarter.
Matisse Capital sold 5,902 InflaRx shares in Q4 2018, an estimated $203K.
Matisse Capital first reported a position in InflaRx in Q3 2018 and held it in 1 quarter.
Matisse Capital's InflaRx position peaked at $203K in Q3 2018.
34 funds tracked by Wall St. Rank held InflaRx as of Q4 2018.

Based on Matisse Capital's 13F filing for Q4 2018, filed 18 Jan 2019.